Back to search

Peptide record

TPDB08828

Antibacterial Anticancer Antifungal Toxicity standard
18 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB08828
Antibacterial Anticancer Antifungal Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
AntiBP3 dbAMP DRAMP Peptipedia CancerPPD 2.0 dbACP dbAMP 3.0 Antifungipept
standard
No
A 18-aa standard natural multi-activity (Antibacterial, Anticancer, Antifungal, and other sources) peptide sequence curated from AntiBP3, dbAMP, DRAMP, and other sources, with an available 3D structural model.
Sequence
GCRRLCWKQRCVTYCRGR
Physicochemical Analysis
C92H154N36O22S4
ANDEHIMFPS
R
2244.70
10.41
6
0
4
+6
1.54
-0.867
37.78
Mammalian: 30 hour Yeast: >20 hour E.coli: >10 hour
7240
322.54
7
Residue Composition
number
0
A
5
R
0
N
0
D
4
C
0
E
1
Q
2
G
0
H
0
I
1
L
1
K
0
M
0
F
0
P
0
S
1
T
1
W
1
Y
1
V
Amino Acid Distribution
A: 0 R: 5 N: 0 D: 0 C: 4 E: 0 Q: 1 G: 2 H: 0 I: 0 L: 1 K: 1 M: 0 F: 0 P: 0 S: 0 T: 1 W: 1 Y: 1 V: 1
Chemical Descriptors
18
C92H154N36O22S4
2244.70
10.41
+6
1.54
-0.867
Evidence Records 3 records
Evidence 1 Activity

Activity

45.3±10.2% Hemolysis
Toxicity
64 µM
Hemolytic Cytotoxic
45.3±10.2% Hemolysis | 64 | µM | target cell: Human erythrocytes

Target

Human erythrocytes

Source & Reference

NA
DBAASP
Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties. | ACS Chem Biol | 2017
Evidence 2 Activity

Activity

CC50
Toxicity
39.7±3.8 µM
Cytotoxic
CC50 | 39.7±3.8 | µM | target cell: Human foreskin fibroblasts (HFF)

Target

Human foreskin fibroblasts (HFF)

Source & Reference

NA
DBAASP
Redesigned Spider Peptide with Improved Antimicrobial and Anticancer Properties. | ACS Chem Biol | 2017
Evidence 3 Activity

Activity

% Hemolysis
Toxicity
55.5 %
Hemolytic Cytotoxic
Hemolytic_activity: [Ref.28741926] 35.1-55.5% hemolysis at 64 µM against human red blood cells | Cytotoxicity: [Ref.28741926] CC50 = 23.3 ± 0.4 µM against CRL-1739, CC50 = 5.1 ± 0.3 µM against MM96L, CC50 = 39.7 ± 3.8 µM against HFF-1, CC50 > 64 µM against HeLa, CC50 = 3.9 ± 0.2 µM against K-562.

Target

erythrocytes

Source & Reference

NA
DRAMP
ACS Chem Biol. 2017 Sep 15 12(9):2324-2334. doi: 10.1021/acschembio.7b00459.?